Functional Switching of TGF-β1 Signaling in Liver Cancer via Epigenetic Modulation of a Single CpG Site in TTP Promoter

Gastroenterology

Volumn 138, Issue 5, 2010, Pages

  Sohn, Bo Hwa ^a,b   Park, In Young ^a   Lee, Jung Ju ^a   Yang, Suk Jin ^a   Jang, Ye Jin ^a   Park, Kyung Chan ^a   Kim, Dong Joon ^a   Lee, Dong Chul ^a   Sohn, Hyun Ahm ^a   Kim, Tae Woo ^a   Yoo, Hyang Sook ^a   Choi, Jong Young ^c   Bae, Yun Soo ^b   Yeom, Young Il ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Ewha Womans University   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

HCC; Methylation; TGF 1; TTP

Indexed keywords

MESSENGER RNA; MYC PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRISTETRAPROLIN;

ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; CPG ISLAND; DNA BINDING; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION; GENE FUNCTION; GENE INACTIVATION; HUMAN; HUMAN TISSUE; LIVER CANCER; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION;

EID: 77951667118     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.12.044     Document Type: Article

References (30)

1. Derynck R., Akhurst R.J., and Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nat Genet 29 (2001) 117-129
2. Seoane J. Escaping from the TGF-β antiproliferative control. Carcinogenesis 27 (2006) 2148-2156
3. Pelengaris S., Khan M., and Evan G. c-MYC: more than just a matter of life and death. Nat Rev Cancer 2 (2002) 764-776
4. Chen C.R., Kang Y., and Massague J. Defective repression of c-myc in breast cancer cells: a loss at the core of the transforming growth factor β growth arrest program. Proc Natl Acad Sci U S A 98 (2001) 992-999
5. Baldwin R.L., Tran H., and Karlan B.Y. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor β growth arrest independent of transforming growth factor β/Smad signaling. Cancer Res 63 (2003) 1413-1419
6. Frederick J.P., Liberati N.T., Waddell D.S., et al. Transforming growth factor β-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element. Mol Cell Biol 24 (2004) 2546-2559
7. Coffey Jr. R.J., Bascom C.C., Sipes N.J., et al. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor β. Mol Cell Biol 8 (1988) 3088-3093
8. Marderosian M., Sharma A., Funk A.P., et al. Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling. Oncogene 25 (2006) 6277-6290
9. Carballo E., Lai W.S., and Blackshear P.J. Feedback inhibition of macrophage tumor necrosis factor-α production by tristetraprolin. Science 281 (1998) 1001-1005
10. Lai W.S., Stumpo D.J., and Blackshear P.J. Rapid insulin-stimulated accumulation of an mRNA encoding a proline-rich protein. J Biol Chem 265 (1990) 16556-16563
11. Ogawa K., Chen F., Kim Y.J., et al. Transcriptional regulation of tristetraprolin by transforming growth factor-β in human T cells. J Biol Chem 278 (2003) 30373-30381
12. Lykke-Andersen J., and Wagner E. Recruitment and activation of mRNA decay enzymes by two ARE-mediated decay activation domains in the proteins TTP and BRF-1. Genes Dev 19 (2005) 351-361
13. Stoecklin G., Tenenbaum S.A., Mayo T., et al. Genome-wide analysis identifies interleukin-10 mRNA as target of tristetraprolin. J Biol Chem 283 (2008) 11689-11699
14. Johnson B.A., Geha M., and Blackwell T.K. Similar but distinct effects of the tristetraprolin/TIS11 immediate-early proteins on cell survival. Oncogene 19 (2000) 1657-1664
15. Stoecklin G., Gross B., Ming X.F., et al. A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA. Oncogene 22 (2003) 3554-3561
16. Park I.Y., Sohn B.H., Choo J.H., et al. Deregulation of DNA methyltransferases and loss of parental methylation at the insulin-like growth factor II (Igf2)/H19 loci in p53 knockout mice prior to tumor development. J Cell Biochem 94 (2005) 585-596
17. Kobor M.S., and Greenblatt J. Regulation of transcription elongation by phosphorylation. Biochim Biophys Acta 1577 (2002) 261-275
18. Clayton A.L., Hazzalin C.A., and Mahadevan L.C. Enhanced histone acetylation and transcription: a dynamic perspective. Mol Cell 23 (2006) 289-296
19. Ross S., Cheung E., Petrakis T.G., et al. Smads orchestrate specific histone modifications and chromatin remodeling to activate transcription. EMBO J 25 (2006) 4490-4502
20. Wade P.A. Methyl CpG-binding proteins and transcriptional repression. Bioessays 23 (2001) 1131-1137
21. Akiyoshi S., Inoue H., Hanai J., et al. c-Ski acts as a transcriptional co-repressor in transforming growth factor-β signaling through interaction with smads. J Biol Chem 274 (1999) 35269-35277
22. Jones P.A., and Baylin S.B. The fundamental role of epigenetic events in cancer. Nat Rev Genet 3 (2002) 415-428
23. Turker M.S. Gene silencing in mammalian cells and the spread of DNA methylation. Oncogene 21 (2002) 5388-5393
24. Jones B., and Chen J. Inhibition of IFN-γ transcription by site-specific methylation during T helper cell development. EMBO J 25 (2006) 2443-2452
25. Zou B., Chim C.S., Zeng H., et al. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers. Gastroenterology 131 (2006) 1835-1843
26. Taylor G.A., Carballo E., Lee D.M., et al. A pathogenetic role for TNF α in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4 (1996) 445-454
27. Raghavan A., Robison R.L., McNabb J., et al. HuA and tristetraprolin are induced following T-cell activation and display distinct but overlapping RNA binding specificities. J Biol Chem 276 (2001) 47958-47965
28. Young L.E., Sanduja S., Bemis-Standoli K., et al. The mRNA binding proteins HuR and Tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis. Gastroenterology 136 (2009) 1669-1679
29. Essafi-Benkhadir K., Onesto C., Stebe E., et al. Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation. Mol Biol Cell 18 (2007) 4648-4658
30. Gebeshuber C.A., Zatloukal K., and Martinez J. miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep 10 (2009) 400-405